Finally, cyclin D1 is frequently overexpressed in ductal carcinoma in situ, and also in some benign breast diseases (Weinstat-Saslow et al, 1995; Alle et al, 1998), pointing to a role in the earliest stages of breast tumour development. Here, CCND1 is linked to breast neoplasm.